Inventor · disambiguated record
Nageswara R. Palepu
Also filed as: PALEPU NAGESWARA R
25 granted patents·15 pending applications·537 citations·filing 1987–2023
97Inventor score
Files withPALEPU NAGESWARA R10EAGLE PHARMACEUTICALS INC8SMITHKLINE BEECHAM CORP8ERBAMONT INC6SCIDOSE LLC3
Top patents by PatentIndex Score
40 records- 0197US8158152B2Lyophilization process and products obtained therebyPALEPU NAGESWARA R·Filed 2005·Granted Apr 17, 2012·70 cites·46 claims
- 0292US6475510B1Process for manufacturing bite-dispersion tabletsSMITHKLINE BEECHAM CORP·Filed 1998·Granted Nov 5, 2002·136 cites·101 claims
- 0388US6630498B2Eprosartan arginyl charge-neutralization-complex and a process for its preparation and formulationSMITHKLINE BEECHAM CORP·Filed 2001·Granted Oct 7, 2003·28 cites·17 claims
- 0488US2024082264A1Fulvestrant formulationsEAGLE PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0587US8912228B2Docetaxel formulations with lipoic acidPALEPU NAGESWARA R·Filed 2011·Granted Dec 16, 2014·5 cites·20 claims
- 0687US7589106B2Alcohol free formulation of argatrobanEAGLE PHARMACEUTICALS INC·Filed 2007·Granted Sep 15, 2009·4 cites·23 claims
- 0786US9180088B2Fulvestrant formulationsPALEPU NAGESWARA R·Filed 2009·Granted Nov 10, 2015·5 cites·23 claims
- 0883US8541465B2Docetaxel formulations with lipoic acid and/or dihydrolipoic acidPALEPU NAGESWARA R·Filed 2009·Granted Sep 24, 2013·2 cites·20 claims
- 0983US2022387446A1Fulvestrant formulationsEAGLE PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1080US6420412B2Eprosartan dihydate and a process for its production and formulationSMITHKLINE BEECHAM CORP·Filed 2001·Granted Jul 16, 2002·11 cites·41 claims
- 1179US5002774ASustained release pharmaceutical tabletERBAMONT INC·Filed 1989·Granted Mar 26, 1991·76 cites·26 claims
- 1277US2020188411A1Fulvestrant formulationsEAGLE PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1374US9801892B2Fulvestrant formulationsHAZ TWO LLC·Filed 2015·Granted Oct 31, 2017·1 cites·22 claims
- 1474US2021260076A1Fulvestrant formulationsEAGLE PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1572US8815833B2Stable amifostine liquid concentratePALEPU NAGESWARA R·Filed 2007·Granted Aug 26, 2014·1 cites·11 claims
- 1671US6743414B2Inhalation administration of biophosphonatesGENEVA PHARMACEUTICALS INC·Filed 2002·Granted Jun 1, 2004·4 cites·6 claims
- 1771US5690959APharmaceutical thermal infusion processSMITHKLINE BEECHAM CORP·Filed 1994·Granted Nov 25, 1997·33 cites·34 claims
- 1869US2008319048A1Solubilized formulation of docetaxel without tween 80SCIDOSE LLC·Filed 2008·Application pending·0 cites
- 1964US10363259B2Fulvestrant formulationsHAZ TWO LLC·Filed 2017·Granted Jul 30, 2019·0 cites·17 claims
- 2064US2011092579A1Solubilized formulation of docetaxelSCIDOSE LLC·Filed 2009·Application pending·0 cites
- 2162US5268368ACyclophosphamide--amino acid lyophilizatesERBAMONT INC·Filed 1991·Granted Dec 7, 1993·26 cites·8 claims
- 2261US6262102B1Eprosartan monohydrateSMITHKLINE BEECHAM CORP·Filed 1998·Granted Jul 17, 2001·17 cites·5 claims
- 2361US2008248115A1Combinations of statins and anti-obesity agentPALEPU NAGESWARA R·Filed 2008·Application pending·0 cites
- 2460US2008249141A1Co-therapy with and combinations of statins and 1,4-dihydropyridine-3,5-dicarboxydiestersPALEPU NAGESWARA R·Filed 2008·Application pending·0 cites
- 2556US2010076019A1Alcohol free formulation of argatrobanEAGLE PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 2655US5130305ACyclophosphamide - sodium bicarbonate lyophilizatesERBAMONT INC·Filed 1990·Granted Jul 14, 1992·22 cites·13 claims
- 2754US5418223AMethod for lyophilization of cyclophosphamide and productERBAMONT INC·Filed 1994·Granted May 23, 1995·21 cites·10 claims
- 2853US5827537APharmaceutical thermal infusion processSMITHKLINE BEECHAM CORP·Filed 1995·Granted Oct 27, 1998·14 cites·5 claims
- 2952US2004127466A1Inhalation administration of bisphosphonatesFiled 2003·Application pending·0 cites
- 3051US7687516B2Alcohol free formulation of argatrobanEAGLE PHARMACEUTICALS INC·Filed 2007·Granted Mar 30, 2010·0 cites·22 claims
- 3150US2013023559A1Alcohol free formulation of argatrobanEAGLE PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 3249US5824344APharmaceutical thermal infusion granulesSMITHKLINE BEECHAM CORP·Filed 1995·Granted Oct 20, 1998·10 cites·16 claims
- 3349US5066647ACyclophosphamide - alanine lyophilizatesERBAMONT INC·Filed 1990·Granted Nov 19, 1991·16 cites·6 claims
- 3449US4808617ALyophilized or precipitated cephalosporin zwitterion and salt combinationBRISTOL MYERS CO·Filed 1987·Granted Feb 28, 1989·13 cites·16 claims
- 3549US2010234443A1Combinations of statins and anti-obesity agentSCIDOSE LLC·Filed 2010·Application pending·0 cites
- 3649US2008286373A1Ziprasidone formulationsPALEPU NAGESWARA R·Filed 2008·Application pending·0 cites
- 3749US2008249156A1Combinations of statins and anti-obesity agent and glitazonesPALEPU NAGESWARA R·Filed 2008·Application pending·0 cites
- 3848US2012264817A1Solubilized formulation of docetaxel without tween 80PALEPU NAGESWARA R·Filed 2012·Application pending·0 cites
- 3946US6365196B1Controlled release solid dosage forms of lithium carbonateSMITHKLINE BEECHAM CORP·Filed 1998·Granted Apr 2, 2002·9 cites·8 claims
- 4045US5336669ACyclophosphamide monohydrate and lactoseERBAMONT INC·Filed 1993·Granted Aug 9, 1994·13 cites·4 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →